Wednesday, January 20, 2021
News
NEWS HOME
»
PRESS RELEASES

Phase III InPedILD™ trial enrolls first patient to evaluate nintedanib in pediatric population with fibrosing interstitial lung disease
  SocialTwist Tell-a-Friend  
   


Date: 13-08-2020 10:20AM
Source: Boehringer Ingelheim
Category: General, Science & Research, Healthcare & Biotechnology, Pharmaceutical
Location: Ingelheim, Germany

Business Wire India

  • First-of-its-kind clinical trial in children and adolescents with fibrosing interstitial lung disease (ILD) initiated globally
  • This new study builds on the Phase III INBUILD® trial and approval of Ofev® in adult patients with fibrosing ILDs with a progressive phenotype1,2,3
  • Global Phase III multicentre clinical trial is planned to be conducted in approximately 70 sites in 24 countries

Boehringer Ingelheim today announced that the first patient has enrolled in InPedILD™, a global Phase III trial assessing the dosing and safety profile of nintedanib in children and adolescents between six and 17 years old with clinically significant fibrosing interstitial lung disease (ILD).

Childhood ILD (chILD) includes more than 200 rare respiratory disorders that can affect infants, children and adolescents, making it difficult for them to breathe. In some cases, fibrosis which involves scarring and damage to the lungs can develop. This can lead to a significant impact on the daily life of those affected, as well as their families, including high morbidity and mortality. There are currently no approved therapies available for the treatment of chILD.

“Some children with interstitial lung disease may develop serious fibrosis that progresses,” said the coordinating investigator Prof. Robin Deterding, M.D., Director of the Breathing Institute, Children's Hospital Colorado. “Though the underlying causes of pulmonary fibrosis may be different in children, we’re excited to determine if treating the mechanism of fibrosis improves children’s lung fibrosis as it does in adults.”

Nintedanib, which is marketed as Ofev®, is currently approved in more than 80 countries for the treatment of people living with idiopathic pulmonary fibrosis (IPF).4 It is also approved in more than 40 countries as the first and only therapy to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD (SSc-ILD).5 Ofev® recently also obtained approval in the USA, Canada, Japan, Brazil, Argentina and the EU, for a third indication, as the first and only treatment for patients living with chronic fibrosing ILDs with a progressive phenotype.2,3

“Boehringer Ingelheim is proud to start this trial to provide valuable insights as we evaluate this potential treatment for children and adolescents with these rare and heterogenous conditions for which there are currently no treatments with proven efficacy and no randomized controlled trials,” said Dr Susanne Stowasser, Associate Head of Medicine Pulmonology at Boehringer Ingelheim. “This study represents our ongoing commitment to address unmet needs and advance research for adult and pediatric patients living with pulmonary fibrosis.”

~ENDS~

For references and notes to editors, please visit: http://www.boehringer-ingelheim.com/press-release/inpedildtrialenrollment



CONTACTS :

Boehringer Ingelheim
Corporate Communications
Media + PR
Dr Ralph Warsinsky.
55216 Ingelheim/Germany
Phone +49 6132 77 7051
Mobile +49 178 290 8561
Email: press@boehringer-ingelheim.com

More Press Releases

CYNORA Announces Availability of Industry’s First Device Test Kits for TADF Deep Green Emitters for Next-Generation OLED Displays

ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets

PPRO Raises $180 Million for the Next Era of Local Payments Infrastructure, Is Now Valued Over $1 Billion

Loomis Sayles Welcomes Marques Benton as Chief Diversity, Equity and Inclusion Officer

Johns Manville Announces Katie Albery as New General Counsel

Everbridge Unveils Next-Generation Front-End Alerting Interface for Industry-Leading Global Public Warning Platform

Pitney Bowes Appoints Ana Maria Chadwick as Executive Vice President and Chief Financial Officer

Andersen Global Enters Malawi

CGTN:China’s Winter Sports in Full Swing as 2022 Winter Olympics Approaches

Maxon Announces the Acquisition of Japanese Distributor Business

ADROSONIC Expands Business in USA, Announces James Oury as Partner Operations at ADROSONIC Inc.

Bank of America Reports Fourth-Quarter 2020 Financial Results

Velodyne Lidar and Trunk.Tech Announce Strategic Partnership in Autonomous Trucking

Bel Power Solutions and Transphorm Announce Family of Titanium Efficiency AC to DC Power Supplies

Walmart and Western Union Enter Agreement to Offer Western Union Money Transfers at Walmart

B2Broker Introduces Latest Technology Components of B2Trader Matching Engine as a Software Solution

PMI's Charles Bendotti Recognized by INvolve and Yahoo Finance on OUTstanding 50 Ally Executives List 2020; Nikki Symmons named on LGBT+ Future Leader List 2020

Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma

How Can You Treat Diabetes the Ayurvedic Way

Cyber Observer's Latest Release Provides New Visibility Into Cybersecurity Risk Posture

2021 Travel News: Find the Best Value Family Days out With New Price Compare Site tripindicator.com

Asia Invests in Biotechnology Innovations to Boost Food Safety, Sustainability

SSi Canada Partners with SES Networks to Deliver New Satellite Capacity into Northern Canada

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Experts train local residents on how to ...
I-T dept raids 28 properties of TN evang...
Urdu Bulletin: India's historic win agai...
NDA to hold meeting on Jan 30 ahead of b...
Successful protests against IIT-Goa, cou...
AP CM going to Delhi to 'prostrate' befo...
More...    
 
 Top Stories
Emma Roberts on being pregnant duri... 
Kamala Harris native village in Tam... 
Disrupting the Entrepreneurial DNA ... 
DK Shivakumar alleges farmers stopp... 
Afghanistan: 6 policemen wounded in... 
Gold Assaying-Hallmarking Centres: ... 
Motion Education launches exclusive... 
Edge AI company AlphaICs raises $8 ...